Clinical Gastroenterology Vol.22 No.12 ( Nov, 2007)

Thesis List

• 0 Editorial
  Toshifumi Hibi

• 1-1 The Pharmacokinetics of AZA/6-MP -- The General Remarks of Metabolism / Pharmacological Action, and the Gene Polymorphism of Metabolic Enzymes
  Kan Uchiyama

• 1-2 Optimizing Efficacy and Safety of AZA/6-MP for Inflammatory Bowel Disease -- Role of TPMT Polymorphism and 6-TGN
  Hiroyuki Hanai

• 2 Onset of Action of AZA/6-MP in Inflammatory Bowel Diseases
  Masakazu Nagahori

• 3 Optimum Duration of Maintenance Therapy with AZA/6-MP in Inflammatory Bowel Disease
  Yoh Ishiguro

• 4 Role of AZA/6-MP in Inducing Remission of Chronic Inflammatory Bowel Disease
  Shuji Kochi

• 5 The Tailoring Therapy, Adverse Events and Points to Keep in Mind of AZA/6-MP for the Treatment of Inflammatory Bowel Disease
  Shozo Okamura

• 6 Increased Risks of Adverse Effects with AZA/6-MP in Pregnancy
  Fuminao Takeshima

• 7-1 Comparative Effect of Other Treatments with AZA/6-MP in the Steroid Dependent / Resistant Inflammatory Bowel Disease -- Cyclosporin
  Naoki Yoshimura

• 7-2 Comparative Effect of Other Treatments with AZA/6-MP in the Steroid Dependent / Resistant Inflammatory Bowel Disease -- Tacrolimus
  Hiroshi Nakase

• 7-3 Comparative Effect of Other Treatments with AZA/6-MP in the Steroid Dependent / Resistant Inflammatory Bowel Disease -- Cytapheresis (Leukocytic Cytapheresis ; LCP)
  Koji Sawada

• 7-4 Comparative Effect of Other Treatments with AZA/6-MP in the Steroid Dependent / Resistant Inflammatory Bowel Disease -- Infliximab
  Yasuo Suzuki

• 7-5 Comparative Effect of Other Treatments with AZA/6-MP in the Steroid Dependent / Resistant Inflammatory Bowel Disease -- Antibiotic Combination ATM Therapy
  Toshifumi Ohkusa